| abstract |
The present disclosure is directed to a composition or nutritional product containing a cannabinoid in combination with an adjuvant, such as a Type II collagen. The different nutraceutical agents are capable of synergistically working together to improve the health and well-being of a human or animal. For instance, the nutritional product can be used in many different applications, such as to treat joint discomfort and pain, and/or to improve muscular health. |